ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

BioVectra expands in small and large molecules

by Rick Mullin
March 8, 2019 | APPEARED IN VOLUME 97, ISSUE 10

The pharmaceutical services firm BioVectra plans a five-year, $108 million expansion at its biologic drug plant in Nova Scotia and its headquarters plant on Prince Edward Island. The firm will expand microbial fermentation and add mammalian cell culture in Nova Scotia and expand complex and highly potent pharmaceutical chemical manufacturing on PEI. It expects to create 150 full-time jobs. Canadian prime minister Justin Trudeau visited BioVectra’s headquarters to announce a $28 million contribution from the Canadian government.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment